Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
- PMID: 1846105
- DOI: 10.1210/endo-128-1-37
Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
Abstract
It has previously been shown that interleukin-1 (IL-1) directly stimulates the release of CRH-41 from rat hypothalamus in vitro, suggesting that cytokines may mediate the effects of changes in immune state on the hypothalamo-pituitary adrenal axis (HPA). However, it is likely that several cytokines can cause changes in neuroendocrine function, and we have now investigated a series of others for central activity on the HPA: IL-2, IL-6, IL-8, tumor necrosis factor (cachectin), interferon-alpha 2, and interferon-gamma. The static rat hypothalamic incubation system used involves fresh hypothalamic explants with consecutive 20-min incubation, and estimation of CRH-41 concentrations in the medium by a specific RIA; the acute effects of cytokines on ACTH release from rat dispersed pituitary cells were also measured. IL-6 increased hypothalamic CRH-41 secretion in the range 10-100 U/ml, but had no effect on isolated median eminences incubated in vitro under the same conditions. IL-6 (1-1000 U/ml) also had no effect on the secretion of ACTH from freshly dispersed rat anterior pituitary cells when administered in 10-min pulses. The effects of both IL-1 and IL-6 were antagonized by blockade of the eicosanoid cyclooxygenase pathway, but not by lipooxygenase blockade. Neither IL-2 (1-10000 U/ml), IL-8 (0.1-10 nM), tumor necrosis factor (10-1000 U/ml), interferon-alpha 2 (10-1000 U/ml) nor interferon-gamma (10-1000 U/ml) had any effect on hypothalamic CRH-41 release or pituitary ACTH release. It is therefore concluded that IL-6, like IL-1, can exert a potent enhancing effect on the HPA by acutely stimulating the secretion of CRH-41 from the hypothalamus at a site above the level of the median eminence, at concentrations known to occur in human plasma and cerebrospinal fluid. These effects are probably mediated by cyclooxygenase products. Acute stimulatory effects of the other cytokines investigated on the HPA are unlikely to be exerted through changes in either CRH-41 or ACTH directly.
Similar articles
-
Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat.Endocrinology. 1990 Jun;126(6):2876-81. doi: 10.1210/endo-126-6-2876. Endocrinology. 1990. PMID: 2161738
-
The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.J Neuroendocrinol. 1996 Aug;8(8):579-85. J Neuroendocrinol. 1996. PMID: 8866244
-
Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect.Endocrinology. 1991 Sep;129(3):1275-82. doi: 10.1210/endo-129-3-1275. Endocrinology. 1991. PMID: 1678697
-
Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.Front Neuroendocrinol. 1996 Jan;17(1):1-50. doi: 10.1006/frne.1996.0001. Front Neuroendocrinol. 1996. PMID: 8788568 Review.
-
Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.J Endotoxin Res. 2003;9(1):3-24. doi: 10.1179/096805103125001298. J Endotoxin Res. 2003. PMID: 12691614 Review.
Cited by
-
Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids.Endocrine. 2001 Nov;16(2):123-31. doi: 10.1385/ENDO:16:2:123. Endocrine. 2001. PMID: 11887933
-
Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2106868118. doi: 10.1073/pnas.2106868118. Proc Natl Acad Sci U S A. 2021. PMID: 34187898 Free PMC article.
-
Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism.Psychopharmacology (Berl). 2005 Feb;178(1):78-82. doi: 10.1007/s00213-004-1984-6. Epub 2004 Aug 6. Psychopharmacology (Berl). 2005. PMID: 15300357
-
Recent Advances in Electrochemical and Optical Biosensors Designed for Detection of Interleukin 6.Sensors (Basel). 2020 Jan 23;20(3):646. doi: 10.3390/s20030646. Sensors (Basel). 2020. PMID: 31979357 Free PMC article. Review.
-
Effects of pyrogenic immunomodulators on the release of corticotrophin-releasing factor-41 and prostaglandin E2 from the intact rat hypothalamus in vitro.Br J Pharmacol. 1993 May;109(1):88-93. doi: 10.1111/j.1476-5381.1993.tb13535.x. Br J Pharmacol. 1993. PMID: 8495249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources